Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will highlight its innovative offering of products and services for clinical research and specialty diagnostics during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo held in Anaheim, California, July 25 - 29, 2010.
“Building on the strength of our highly recognized brands for clinical research and combining them into an easy-to-use workflow demonstrates for our customers the benefit of working with a single, comprehensive supplier.”
Thermo Fisher will introduce a substantially improved liquid chromatography/mass spectrometry (LC/MS) workflow for immunosuppressant analysis designed to improve productivity in clinical research applications. The seamless integration of instruments, software, consumables and reagents significantly reduces sample preparation time, improves overall performance and provides a total workflow supported by a single supplier. This workflow will be adapted to the analysis of a number of drugs, as well as vitamins and steroids. For more information, visit Booth 2415 at the Anaheim Convention Center.
"This year at AACC, we are highlighting how our scale and depth of capabilities are meeting increasing demand in clinical research and specialty diagnostics markets," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "Building on the strength of our highly recognized brands for clinical research and combining them into an easy-to-use workflow demonstrates for our customers the benefit of working with a single, comprehensive supplier."
Thermo Fisher's focus at this year's AACC meeting is on advancements in both sample preparation and analysis. The company's innovative workflow combines automated sample preparation, a fully contained immunosuppressant test kit, as well as industry-leading LC/MS technology and columns specifically designed for clinical research.
The Thermo Scientific ClinSpec Immunosuppressant Test Kit, for example, provides all the reagents, standards, controls and sample preparation methodology needed to monitor immunosuppressant drugs during research. The kit is part of a total solution for immunosuppressant drug analysis and was developed to provide significant time savings when compared with manual sample preparation. Similarly, the Thermo Scientific Versette automated liquid-handling platform is used to simplify the sample-handling method, whether the research chemist is transitioning from handheld pipetting or establishing an integrated system.
Source Thermo Fisher Scientific
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies